reducing the prevalence of blindness to 0.3% by 2020. A current survey in progress (2015-18)
shows projected rate of prevalence of blindness is 0.45%. Government of India is focused on
lowering this rate to 0.3% by 2020.
In February 1999, the World Health Organization (WHO), together with over 20 international non-
governmental organizations involved in eye care and prevention and management of blindness,
launched VISION 2020, a global initiative that aims to eliminate avoidable blindness by 2020.
Increasing Incidence of Eye Disorders is expected to Augment the Market Growth
Increasing prevalence of eye disorders such as glaucoma, diabetic retinopathy, macular
degeneration, and cataract is expected to drive growth of the ophthalmic devices market. For
instance, according to the International Journal of Advanced Medical and Health Research: 2015,
cataract is a major cause of blindness and affects 17-18 million people worldwide, accounting for
39% of such cases, among overall blindness cases. Following cataract, glaucoma is the second
major cause of blindness worldwide.
According to the BrightFocus Foundation, June 2017 data findings, in 2017; over 3 million
Americans suffer from glaucoma, of which 2.7 million - aged 40 and older - are affected by its
most common form, open-angle glaucoma. Such high numbers are attributed to increasing
prevalence of eye disorder in geriatric population and changing food habits leading to nutritional
deficiency in younger population.
Although glaucoma may occur in people with or without diabetes, those with diabetic retinopathy
have an increased risk of glaucoma. The condition is associated with abnormal blood vessel growth,
which can result in retinopathy to eventually block natural drainage of the eye. According to the
International Diabetes Foundation (IDF) 2017 statistics, prevalence of diabetes is high among
people aged between 20 to 79 years worldwide, of which Africa (156%) accounted for the highest
diabetic population, followed by Middle East (110%), South East Asia (84%), Latin and Central
America (62%), North America (35%), Europe (16%), and Western Pacific (15%).
For More Information @
https://www.coherentmarketinsights.com/market-insight/ophthalmic-devices-market-686
Increasing Adoption of Refurbished Ophthalmic Devices is Expected to Hinder the Market
Growth
Among ophthalmic devices segment, ophthalmic imaging devices in the refurbished form witness
increasing demand due to low production & material cost. However, this adversely affects the sales
of manufacturer build or OEM build ophthalmic devices.
For instance, according to the Refurbishment of Medical Equipment Report on promising Key
Enabling Technologies (KETs)-based product, published by European Commission in August 2017,
refurbished diagnostic imaging equipment accounted for 75.5% of the global demand for
refurbished medical devices, in 2015.
Refurbished medical devices specifically include, diagnostic imaging devices that create visual
representations of internal organs of the body to help in medical intervention and clinical analysis.
Generally, damaged or unused component are replaced with newer and updated components in the
production of refurbished medical devices. Hardware or software may also be upgraded, followed
by extensive testing, quality assurance, and (as required) re-submission for regulatory approval.
Furthermore, high cost of new ophthalmic devices has led to increasing adoption of refurbished
counterparts.